Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
74
SRZN Quote, Financials, Valuation and Earnings
Last price:
$22.14
Seasonality move
:
27.32%
Day range:
$21.34 - $22.99
52-week range:
$5.90 - $24.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
36.96x
P/B ratio:
2.22x
Volume:
29.4K
Avg. volume:
113.1K
1-year change:
50.2%
Market cap:
$190.3M
Revenue:
$10.7M
EPS (TTM):
-$21.83
Analysts' Opinion
-
Consensus RatingSurrozen, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.00, Surrozen, Inc. has an estimated upside of 65.17% from its current price of $22.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $22.20.
Fair Value
-
According to the consensus of 1 analyst, Surrozen, Inc. has 65.17% upside to fair value with a price target of $37.00 per share.
SRZN vs. S&P 500
-
Over the past 5 trading days, Surrozen, Inc. has overperformed the S&P 500 by 1.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Surrozen, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Surrozen, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Surrozen, Inc. reported revenues of $983K.
Earnings Growth
-
Surrozen, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Surrozen, Inc. reported earnings per share of -$8.36.
Enterprise value:
116M
EV / Invested capital:
-7.06x
Price / LTM sales:
36.96x
EV / EBIT:
--
EV / Revenue:
32.20x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-5.52x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.8M
Return On Assets:
-128.47%
Net Income Margin (TTM):
-2909.1%
Return On Equity:
-3865.93%
Return On Invested Capital:
-1136.64%
Operating Margin:
-1107.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $12.5M | $10M | $3.6M | $10M | $983K | |
| Gross Profit | $9.7M | $8.4M | $2.8M | $9.7M | $923K | |
| Operating Income | -$35.5M | -$26.6M | -$38M | $1.2M | -$10.9M | |
| EBITDA | -$32.7M | -$25.1M | -$37.2M | $1.6M | -$10.8M | |
| Diluted EPS | -$17.36 | -$16.99 | -$21.83 | -$0.44 | -$8.36 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $114M | $82.7M | $48.4M | $45.3M | $85.9M | |
| Total Assets | $150.6M | $91.4M | $54M | $48M | $94M | |
| Current Liabilities | $12.5M | $8.7M | $6.7M | $6.1M | $6.5M | |
| Total Liabilities | $26.9M | $13.9M | $8.4M | $42.3M | $117.6M | |
| Total Equity | $123.7M | $77.5M | $45.5M | $5.7M | -$23.5M | |
| Total Debt | $6.1M | $4M | $1.5M | -- | $5.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$33.3M | -$28.4M | -$21M | -$6.8M | -$9M | |
| Cash From Investing | $44.1M | $9.5M | -$88K | -- | -$24K | |
| Cash From Financing | -$2.4M | $16.2M | $71.4M | -$1K | $9K | |
| Free Cash Flow | -$33.8M | -$28.4M | -$21M | -$6.8M | -$9.1M | |
SRZN
Sector
Market Cap
$190.3M
$28.2M
Price % of 52-Week High
89.01%
51.2%
Dividend Yield
0%
0%
Shareholder Yield
-65.51%
-1.54%
1-Year Price Total Return
50.2%
-18.1%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$22.19
200-day SMA
Buy
Level
$11.78
Bollinger Bands (100)
Buy
Level
10.41 - 17.91
Chaikin Money Flow
Buy
Level
35K
20-day SMA
Buy
Level
$20.84
Relative Strength Index (RSI14)
Buy
Level
61.95
ADX Line
Buy
Level
19.46
Williams %R
Neutral
Level
-55.6902
50-day SMA
Buy
Level
$16.36
MACD (12, 26)
Buy
Level
6.13
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
52.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-8.574)
Sell
CA Score
(Annual)
Level (-4.3044)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (11.297)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
Stock Forecast FAQ
In the current month, SRZN has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRZN average analyst price target in the past 3 months is $37.00.
-
Where Will Surrozen, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Surrozen, Inc. share price will rise to $37.00 per share over the next 12 months.
-
What Do Analysts Say About Surrozen, Inc.?
Analysts are divided on their view about Surrozen, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Surrozen, Inc. is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Surrozen, Inc.'s Price Target?
The price target for Surrozen, Inc. over the next 1-year time period is forecast to be $37.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SRZN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Surrozen, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SRZN?
You can purchase shares of Surrozen, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Surrozen, Inc. shares.
-
What Is The Surrozen, Inc. Share Price Today?
Surrozen, Inc. was last trading at $22.14 per share. This represents the most recent stock quote for Surrozen, Inc.. Yesterday, Surrozen, Inc. closed at $22.20 per share.
-
How To Buy Surrozen, Inc. Stock Online?
In order to purchase Surrozen, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SRZN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SRZN
Sector
P/E ratio
--
23.92x
PEG ratio
-0.04x
-0.01x
P/B ratio
2.22x
1.83x
Price / LTM sales
36.96x
1.61x
Growth Metrics
SRZN
Sector
Revenue growth
-90.17%
4.6%
Earnings growth
-1781.77%
10.88%
Revenue (5-year growth)
--
6.46%
Earnings forecast
-$1.17
-$0.21
Profitability
SRZN
Sector
Profitability FY 2024
$9.2M
$3.5M
Return on invested capital
-1136.64%
-31.84%
Return on assets
-128.47%
-27.96%
Return on equity
-3865.93%
-37.63%
Earnings Date
Last Earnings Date
Aug
7
Next Earnings Date
Dec
28
Estimated Next Earnings Date
Mar
29
Balance Sheet
SRZN
Sector
Total cash
$81.3M
$26.3M
Short term investments
--
$25.7M
Total assets
$48.5M
$76.9M
Long term debt
$5.8M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
